Important Patient Safety Information: Coronavirus (COVID-19)

View Menu

GVG the V1P Sponsor for JDRF OneWalk April 13

Categorized In GVG

Grene Vision Group is the V1P Sponsor for the JDRF OneWalk event on Saturday, April 13 at Exploration Place in Wichita. JDRF OneWalk has a single goal: creating a world without type 1 diabetes (T1D). This is GVG’s fourth year as an official sponsor for the event. The OneWalk fundraising goal is $213,750. Miss Kansas Hannah Klaassen will join us in the V1P tent.

Type 1 diabetes is an autoimmune disease in which a person's pancreas loses the ability to produce insulin—a hormone essential to turning food into energy. It strikes both children and adults suddenly and is unrelated to diet and lifestyle. It requires constant carbohydrate counting, blood-glucose testing and lifelong dependence on injected insulin. With T1D there are no days off, and there is no cure. That's why JDRF provides more than 200 walks across the country every year to raise money for JDRF—the only global organization with a strategic research plan to end T1D. Each year, JDRF One Walk brings together more than 900,000 people who raise funds for critical T1D research. This success is only possible because of the support, commitment and strength of our community.

There is NO CHARGE to participate in the event, however registration is appreciated. You can register to walk and raise funds by clicking Wichita JDRF OneWalk Registration.

JDRF OneWalk April 13, 2019


Dr. Campbell Discusses New Glaucoma Medications

Categorized In GVG

For a long time, ophthalmologists had sort of given up on recovering the drainage functions of the trabecular meshwork of a glaucoma patient's eye.

In the past 18 months, the FDA has approved two new glaucoma eyedrop medications and two types of minimally invasive glaucoma surgeries (MIGS) to restore some functionality of the meshwork, said Anita Campbell, MD, a fellowship-trained glaucoma specialist at Grene Vision Group. She has clinics in Wichita and Hutchinson.

Dr. Campbell has started prescribing both new medications – Vyzulta and Rhopressa – and performing both new MIGS procedures – called the Kahook Dual Blade and the OMNI system – to help reduce intraocular pressure (IOP) in the eyes of her glaucoma patients.

Read the article in the February-March 2019 issue of MD News of Greater Kansas magazine by clicking here.

Anita Campbell, MD

March is National Save Your Vision Month

Categorized In GVG

March is National Save Your Vision Month, so be sure to schedule your eye exam today! A complete eye exam is important for all ages and is more than just testing your vision. It's a full checkup for your eyes. Many eye conditions develop very slowly and without symptoms. If left undetected, the conditions may cause irreversible damage to your vision. Regular eye exams are the best way to detect such conditions early and address them before they develop into more serious problems.

Click here to schedule or request an appointment at Grene Vision Group. Or call (316) 636-2010 or the GVG office nearest you.

To learn more about the importance of a complete eye examination, click

Schedule Your Eye Exam